Drug intelligence / Profile preview

CarvaNum

Development stage
Preclinical
Lead developer
Aytu BioPharma
Modality
Small Molecules
Administration
Topical
01

Overview

**CarvaNum** is a proprietary topical muscle-recovery product originated by Innovus Pharmaceuticals. Innovus described the legacy European formulation as a cream containing carvacrol, l-arginine, l-citrulline, and magnesium sulfate, intended to support muscle strength, blood flow, and prevention of muscle cramps; the company received European Union cosmetic-product notification for muscle recovery and stated that it was pursuing a homeopathic-drug filing for muscle cramps in the United States and Canada. ([businesswire.com](https://www.businesswire.com/news/home/20190606005218/en/Innovus-Pharmaceuticals-Receives-Notification-to-Market-and-Sell-CarvaNum%C2%AE-for-Muscle-Recovery-in-the-European-Union)) A separately documented U.S. OTC NDC listing under the same brand identifies CarvaNum as a menthol 0.5% topical lotion for temporary relief of minor muscle and joint aches and pains, indicating that the brand name has been associated with formulation-specific products. ([fda.report](https://fda.report/NDC/57483-301))

Brand names
CarvaNum

Beyond the preview

Go deeper on CarvaNum.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on CarvaNum.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call